Asthmatx, Inc., which was acquired by Boston Scientific, successfully developed and received FDA marketing approval for a less-invasive, catheter-based bronchial thermoplasty procedure for the treatment of severe persistent asthma.

The procedure could benefit an estimated 6 to 8 million patients 18 years and older worldwide whose asthma is not well controlled with drugs (inhaled medications).

Contact Info

888 Ross Drive, Sunnyvale, CA, 94089
Tel: 408-419-0100

Polaris Lead

Brian Chee

Follow on TwitterVisit our Twitter page
Social Media